Filter
190
Filtered Results: 190
Text search:
Bedaquiline
Featured
Recommendations
34
New Publications
54
Language
Document type
No document type
121
Guidelines
25
Studies & Reports
20
Manuals
10
Fact sheets
5
Training Material
3
Situation Updates
3
Strategic & Response Plan
3
Countries / Regions
Western and Central Europe
20
Eastern Europe
16
India
12
Germany
4
Asia
3
South Africa
3
Uganda
3
Ethiopia
3
El Salvador
2
Latin America and the Carribbean
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bolivia
2
Argentina
2
Russia
2
Nepal
1
Kenya
1
Ukraine
1
Nigeria
1
Estonia
1
Malawi
1
Philippines
1
Global
1
Dominican Republic
1
Paraguay
1
Bangladesh
1
Brazil
1
Namibia
1
Romania
1
Georgia
1
Botswana
1
Zambia
1
Authors & Publishers
Publication Years
Category
TB
35
Policies & Guidelines HIV & TB
32
Drugs & Medical Equipment
6
Statistics
5
Pediatrics
3
Studies & Reports
3
Bacteriology
2
Disease Prevention & Control
2
Communicable Diseases
1
Buruli Ulcer
1
COVID-19
1
x MEDBOX Issue Brief & Annual Reports x
1
Palliative Care
1
Countries
1
Policies
1
Guidelines
1
Capacity Building
1
Palliative Care
1
General Guidelines
1
Toolboxes
Drug resistant TB
37
Adults
18
Detection & Diagnosis
18
Prevention & Control
16
Children
13
Reports
10
Eastern Europe & Central Asia
10
Research & Access
7
Policies & Strategies
6
Childhood TB
6
Training
6
General
5
Other Countries
4
Disease Prevention & Control
4
Germany
4
SEAR (South-east Asia Region)
4
Moldova
3
TB & Other Vulnerable Populations
3
Drug resistance
3
Essential Medicines
3
Essential Medicines & Devices Lists
3
HIV &TB
3
Co-Morbidities (except TB)
3
TB & Prisoners
3
Ukraine
2
TB
2
Georgia
2
Russia
2
Ethiopia
2
Studies
2
TB/COVID-19
2
Advocacy & Communication
2
Latin America
2
El Salvador
2
Prices and Patents
2
Argentina
2
Romania
2
Western & Central Europe
2
TB
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Clinical Aspects
1
Children & Adolescents
1
Prophylaxis
1
African Region
1
Country Guidelines
1
Belarus
1
Communication & Training
1
General
1
Research & Development
1
General
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Latin America
1
Estonia
1
Rational use of Medicine
1
Health Care In Conflict Settings
1
Studies & Reports
1
Armenia
1
Policies and guidelines
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
TB/HIV Global
1
Latin America & the Carribean
1
Assessment
1
TB/HIV Coinfection
1
Kazakhstan
1
AmR (Region of Americas)
1
Antiretroviral Treatment ART
1
Kenya
1
AMR
1
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
Surveillance Report
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
